A CASE REPORT ON PHENYTOIN INDUCED ATAXIA
Abstract
ABSTRACT
Phenytoin is commonly used anticonvulsant drug which has several adverse effects such as motor ataxia, dizziness, and visual disturbance. Here,
we report a case of phenytoin toxicity presenting with behavioral disorder ensuring from underlying primary adverse effects of phenytoin that were
clinically unnoted. A termination of phenytoin resulted in remission of side effects.
Keywords: Phenytoin toxicity, Anticonvulsant drug, Behavioral disorder.
Downloads
References
REFERENCES
Browne TR. Phenytoin and other hydantoins. In: Engel J Jr, Pedley TA,
editors. Epilepsy: A Comprehensive Textbook. Philadelphia, PA:
Lippincott – Raven; 1987. p. 1557-79.
Iivanainen M, Savolainen H. Side effects of phenobarbital and
phenytoin during long-term treatment of epilepsy. Acta Neurol Scand
Suppl 1983;97:49-67.
Larsen JR, Larsen LS. Clinical features and management of poisoning
due to phenytoin. Med Toxicol Adverse Drug Exp 1989;4(4):229-45.
Cohen AF, Ashby L, Crowley D, Land G, Peck AW, Miller AA.
Lamotrigine (BW430C), a potential anticonvulsant. Effects on the
central nervous system in comparison with phenytoin and diazepam. Br
J Clin Pharmacol 1985;20(6):619-29.
Madhusudan Singh S, Kuldip K. Usual erratic phenomenon, dramatic
outcome: A case report of phenytoin toxicity. Bull Clin Psychopharmacol
;23(1):81-3.
Tolosa E, Alom I, Marti MJ. Drug-induced dyskinesias. In: Jankovic J,
Tolosa E, editors. Parkinson’s Disease and Movement Disorders. 2
ed.
Baltimore: Williams and Wilkins; 1992. p. 375-97.
Chadwick D, Reynolds EH, Marsden CD. Anticonvulsant-induced
dyskinesias: A comparison with dyskinesias induced by neuroleptics.
J Neurol Neurosurg Psychiatry 1976;39(12):1210-8.
Duarte J, Sempere AP, Cabezas MC, Marcos J, ClaverÃa LE.
Postural myoclonus induced by phenytoin. Clin Neuropharmacol
;19(6):536-8.
Filloux F, Thompson JA. Transient chorea induced by phenytoin.
J Pediatr 1987;110(4):639-41.
Buchthal F, Svensmark O, Schiller PJ. Clinical and
electroencephalographic correlations with serum levels of
diphenylhydanotin. Arch Neurol 1960;2:624-30.
Kokenge R, Kutt H, Mcdowell F. Neurological sequelae following
dilantin overdose in a patient and in experimental animals. Neurology
;15:823-9.
Ghatak NR, Santoso RA, McKinney WM. Cerebellar degeneration
following long-term phenytoin therapy. Neurology 1976;26(9):818-20.
Ney GC, Lantos G, Barr WB, Schaul N. Cerebellar atrophy in
patients with long-term phenytoin exposure and epilepsy. Arch Neurol
;51(8):767-71.
Hussein A, Abdulgalil A, Omer F, Eltoum H, Hamad A, El-Adil O,
et al. Correlation between serum level of antiepileptic drugs and their
side effects. Oman Med J 2010;25(1):17-21.
Lüders H, Acharya J, Baumgartner C, Benbadis S, Bleasel A,
Burgess R, et al. Semiological seizure classification. Epilepsia
;39(9):1006-13.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.